OMGeneOMGene
OMGene

OMGene

OMGene is a biotechnology company focused on developing gene therapies for rare genetic diseases.

Website
2017Active14
Advertise here
About
OMGene is a technology-driven biopharmaceutical company focused on developing and manufacturing complex generic APIs, including peptides, semi-synthetics, synthetic molecules, and oligonucleotides. They also engage in formulation development for injectables and oral peptide delivery. Omgene aims to provide affordable, high-quality healthcare solutions for therapeutic areas such as anti-cancer, anti-diabetic, infertility, and obesity.

Technology stack

detected 2026-05-25
Est. monthly stack spend~$170/mo
Emailunknown
Hosting
self_managed
Stack
Bootstrap
Frequently asked

What does OMGene do?

OMGene is a technology-driven biopharmaceutical company focused on developing and manufacturing complex generic APIs, including peptides, semi-synthetics, synthetic molecules, and oligonucleotides. They also engage in formulation development for injectables and oral peptide delivery. Omgene aims to provide affordable, high-quality healthcare solutions for therapeutic areas such as anti-cancer, anti-diabetic, infertility, and obesity.

How much funding has OMGene raised?

OMGene has raised a total of $10M in funding. The most recent round on record is Seed.

Where is OMGene headquartered?

OMGene is headquartered in Boston, United States.

When was OMGene founded?

OMGene was founded in 2017.

What industry does OMGene operate in?

OMGene operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Gene Therapy.

How many employees does OMGene have?

OMGene has approximately 14 people on record.